Literature DB >> 4440577

Unexpected findings with apomorphine and their possible consequences.

G C Cotzias, I Mena, P S Papavasiliou, J Mendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4440577

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  5 in total

1.  Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.

Authors:  A Colzi; K Turner; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

2.  Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.

Authors:  R J Baldessarini; N S Kula; K G Walton
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

3.  Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease.

Authors:  R J Uitti; J E Ahlskog
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

4.  Suppression of REM rebound by Pergolide.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

5.  Effects of DA agonist in Huntington disease hyperkinesia.

Authors:  T A Caraceni; F Girotti; P Giovannini; M Pederzoli; E A Parati
Journal:  Ital J Neurol Sci       Date:  1980-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.